Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
9.67
-0.24 (-2.42%)
Mar 31, 2025, 9:45 AM EDT - Market open
Certara Revenue
In the year 2024, Certara had annual revenue of $385.15M with 8.70% growth. Certara had revenue of $100.36M in the quarter ending December 31, 2024, with 14.03% growth.
Revenue (ttm)
$385.15M
Revenue Growth
+8.70%
P/S Ratio
4.13
Revenue / Employee
$249,125
Employees
1,546
Market Cap
1.56B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CERT News
- 25 days ago - Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - GlobeNewsWire
- 4 weeks ago - Certara, Inc. (CERT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Certara Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Certara Showcases 2024 Research Wins With Over 100 Papers Published - GlobeNewsWire
- 5 months ago - Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha